Contrave ER 8-90 MG tablet 120S
Ended Awarded
- Contract number
- SPE2DB25FX45Y
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $1,655
Award facts
- Contract value 100% obligated
- $1,654.88 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 12, 2025, for the supply of Contrave ER 8-90 mg tablets (120-count), with a contract ceiling value of $1,654.88. This is a firm fixed-price delivery order with no set-aside designation, indicating it was competitively awarded. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive pharmaceutical support vehicle for military healthcare systems.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, has been selected through open competition to fulfill this federal medical procurement requirement. The company maintains an extensive portfolio of federal contract awards primarily with the Defense Logistics Agency and its Medical Supply Chain, delivering a comprehensive range of pharmaceutical products including brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains. Contrave ER is an obesity management medication, supporting the Defense Health Agency's pharmaceutical needs for military personnel and beneficiaries. The contract is scheduled for ultimate completion by September 15, 2025, reflecting the expedited nature of this delivery order under the existing prime indefinite delivery vehicle.
Quick answers
Who was awarded contract SPE2DB25FX45Y?
SPE2DB25FX45Y was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on September 12, 2025.
How much is contract SPE2DB25FX45Y worth?
The government has obligated $1,655 on SPE2DB25FX45Y.
Is contract SPE2DB25FX45Y an order under another contract?
Yes. SPE2DB25FX45Y is a delivery order under SPE2DB20D2200, an indefinite delivery contract.
Was contract SPE2DB25FX45Y competed?
The extent of competition for SPE2DB25FX45Y was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award